Carolyn M. Mulroney
Hematology
3150 N Tenaya Way Ste 520
Las Vegas, NV 89128
Las Vegas, NV 89128
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Treatment of an Indolent T-Cell Lymphoma of the Gastrointestinal Tract Harboring STAT3::JAK2 With Jakafi (Ruxolitinib) With Significant Clinical Improvements.
Journal: EJHaem
Published: January 06, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
Journal: Blood advances
Published: October 17, 2024
Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 08, 2022
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 07, 2022
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome.
Journal: Transplantation and cellular therapy
Published: August 18, 2021
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas.
Journal: Transplantation and cellular therapy
Published: August 05, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Journal: British journal of haematology
Published: December 18, 2020
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma.
Journal: Frontiers in oncology
Published: October 22, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 06, 2020
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.
Journal: Cancers
Published: November 19, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 11, 2018
Last Updated: 09/26/2026